ACONW Projected Dividend Yield

Wt Exp/Aclarion Inc ( NASDAQ : ACONW )

Aclarion is a healthcare technology company. The first application of Co.'s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Co.'s commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. The main technology underlying NOCISCAN-LS is the use of Magnetic Resonance spectroscopy to identify the chemical makeup of intervertebral discs with a focus on identifying specific proprietary biomarkers.

20 YEAR PERFORMANCE RESULTS